Advanced

Number of patients potentially eligible for proton therapy

Glimelius, B; Ask, Anders LU ; Bjelkengren, Göran LU ; Bjork-Eriksson, T; Blomquist, E; Johansson, B; Karlsson, M and Zackrisson, B (2005) In Acta Oncologica 44(8). p.836-849
Abstract
A group of Swedish radiation oncologists and hospital physicists have estimated the number of patients in Sweden suitable for proton beam therapy in a facility where one of the principal aims is to facilitate randomized and other studies in which the advantage of protons can be shown and the magnitude of the differences compared with optimally administered conventional radiation treatment, also including intensity-modulated radiation therapy (IMRT) and brachytherapy, can be shown. The estimations have been based on current statistics of tumour incidence in Sweden, number of patients potentially eligible for radiation treatment, scientific support from clinical trials and model dose planning studies and knowledge of the dose-response... (More)
A group of Swedish radiation oncologists and hospital physicists have estimated the number of patients in Sweden suitable for proton beam therapy in a facility where one of the principal aims is to facilitate randomized and other studies in which the advantage of protons can be shown and the magnitude of the differences compared with optimally administered conventional radiation treatment, also including intensity-modulated radiation therapy (IMRT) and brachytherapy, can be shown. The estimations have been based on current statistics of tumour incidence in Sweden, number of patients potentially eligible for radiation treatment, scientific support from clinical trials and model dose planning studies and knowledge of the dose-response relations of different tumours together with information on normal tissue complication rates. In Sweden, it is assessed that between 2200 and 2500 patients annually are eligible for proton beam therapy, and that for these patients the potential therapeutic benefit is so great as to justify the additional expense of proton therapy. This constitutes between 14- 15% of all irradiated patients annually. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Acta Oncologica
volume
44
issue
8
pages
836 - 849
publisher
Taylor & Francis
external identifiers
  • wos:000233855500007
  • pmid:16332591
  • scopus:28844435764
ISSN
1651-226X
DOI
10.1080/02841860500361049
language
English
LU publication?
yes
id
aba4695f-e4f4-4f99-a136-718e233c3e00 (old id 211259)
date added to LUP
2007-08-20 11:41:58
date last changed
2017-01-01 07:24:45
@article{aba4695f-e4f4-4f99-a136-718e233c3e00,
  abstract     = {A group of Swedish radiation oncologists and hospital physicists have estimated the number of patients in Sweden suitable for proton beam therapy in a facility where one of the principal aims is to facilitate randomized and other studies in which the advantage of protons can be shown and the magnitude of the differences compared with optimally administered conventional radiation treatment, also including intensity-modulated radiation therapy (IMRT) and brachytherapy, can be shown. The estimations have been based on current statistics of tumour incidence in Sweden, number of patients potentially eligible for radiation treatment, scientific support from clinical trials and model dose planning studies and knowledge of the dose-response relations of different tumours together with information on normal tissue complication rates. In Sweden, it is assessed that between 2200 and 2500 patients annually are eligible for proton beam therapy, and that for these patients the potential therapeutic benefit is so great as to justify the additional expense of proton therapy. This constitutes between 14- 15% of all irradiated patients annually.},
  author       = {Glimelius, B and Ask, Anders and Bjelkengren, Göran and Bjork-Eriksson, T and Blomquist, E and Johansson, B and Karlsson, M and Zackrisson, B},
  issn         = {1651-226X},
  language     = {eng},
  number       = {8},
  pages        = {836--849},
  publisher    = {Taylor & Francis},
  series       = {Acta Oncologica},
  title        = {Number of patients potentially eligible for proton therapy},
  url          = {http://dx.doi.org/10.1080/02841860500361049},
  volume       = {44},
  year         = {2005},
}